GLP-1
3 pieces tagged “GLP-1”.
-
Using a GLP‑1 Medicine Long Term: How Long Trials Ran, What Labels Warn About, and What Happened After Stopping
Major trials followed people for a few years, labels carry serious warnings, and in withdrawal studies much of the weight change did not stay off. Here are the numbers and the questions to take to the prescriber.
-
Do GLP‑1 Medicines Extend Lifespan? No FDA-Approved GLP‑1 Is Labeled for Longevity
Approved GLP-1 uses are specific: blood sugar, weight, and certain heart or kidney risks in defined groups. The outcome trials were not lifespan studies, and research-use vials are not a longevity protocol.
-
Semaglutide, Heart Risk and Kidneys: What SELECT, FLOW and SUSTAIN 6 Showed, and in Whom
Large trials found fewer serious heart or kidney events in the specific groups they enrolled. Here are the numbers from SELECT, FLOW and SUSTAIN 6, and why each result stays inside its own population.
